carmustine has been researched along with Hyperplasia in 1 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganter, B | 1 |
| Tugendreich, S | 1 |
| Pearson, CI | 1 |
| Ayanoglu, E | 1 |
| Baumhueter, S | 1 |
| Bostian, KA | 1 |
| Brady, L | 1 |
| Browne, LJ | 1 |
| Calvin, JT | 1 |
| Day, GJ | 1 |
| Breckenridge, N | 1 |
| Dunlea, S | 1 |
| Eynon, BP | 1 |
| Furness, LM | 1 |
| Ferng, J | 1 |
| Fielden, MR | 1 |
| Fujimoto, SY | 1 |
| Gong, L | 1 |
| Hu, C | 1 |
| Idury, R | 1 |
| Judo, MS | 1 |
| Kolaja, KL | 1 |
| Lee, MD | 1 |
| McSorley, C | 1 |
| Minor, JM | 1 |
| Nair, RV | 1 |
| Natsoulis, G | 1 |
| Nguyen, P | 1 |
| Nicholson, SM | 1 |
| Pham, H | 1 |
| Roter, AH | 1 |
| Sun, D | 1 |
| Tan, S | 1 |
| Thode, S | 1 |
| Tolley, AM | 1 |
| Vladimirova, A | 1 |
| Yang, J | 1 |
| Zhou, Z | 1 |
| Jarnagin, K | 1 |
1 other study available for carmustine and Hyperplasia
| Article | Year |
|---|---|
Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action.
Topics: 5-Aminolevulinate Synthetase; Animals; Antineoplastic Agents; Automation; Bile Ducts; Biotechnology; | 2005 |